title: Safety of intravenous sedation administered by the operating oral surgeon: the second 7 years of office practice.
abstract: OBJECTIVE
  This follow-up study provides an additional 7 years of data (December 2001 through November 2008) pertaining to complications that occurred in patients who received intravenous sedation in the practice of a single board-certified oral and maxillofacial surgeon. Together with the previously published 7 years of data (December 1994 through November 2001), this study summarizes the frequency of various complications encountered in patients sedated intravenously by the surgeon over a 14-year period.
  
  
  METHODS
  The files of intravenous sedation cases from the second 7-year period were reviewed for complications. These data were then compared, contrasted, and combined with the previously published sedation cases from the first 7 years.
  
  
  RESULTS
  A total of 3,320 sedations were performed by the surgeon during this second 7-year period, with only 1.57% of patients having complications (52 patients having 60 adverse events). These results showed a slight decline in the frequency of complications. Over the entire 14-year period of study, a total of 6,209 sedations were performed by the surgeon, with 1.96% of patients having complications (122 patients having 137 adverse events). There were no deaths, and no patients required emergency transport to a hospital.
  
  
  CONCLUSIONS
  The results of this follow-up study confirm the previous findings. The administration of intravenous sedation by the operating surgeon for outpatient oral surgery is safe, with a low frequency of complications. Numerous patients were also made aware of previously undiagnosed medical problems, improving overall patient health.
authors: Indiana University, USA.
authors: Steven F
authors: SF
authors: Rodgers
authors: Matthew S
authors: MS
authors: Rodgers
mesh_terms: D000328:Adult; D000368:Aged; D000556:Ambulatory Surgical Procedures; D000766:Anesthesia, Dental / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects*; D016292:Procedural Sedation / Q000009:adverse effects* / Q000379:methods; D054810:Deep Sedation / Q000009:adverse effects* / Q000379:methods; D004155:Diphenhydramine / Q000008:administration & dosage / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008614:Meperidine / Q000008:administration & dosage / Q000009:adverse effects; D008874:Midazolam / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D020250:Postoperative Nausea and Vomiting / Q000209:etiology; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects; D011595:Psychomotor Agitation / Q000209:etiology; D012189:Retrospective Studies; D013515:Surgery, Oral; D013575:Syncope / Q000209:etiology; D055815:Young Adult
chemical_list: D018686:Anesthetics, Intravenous; D004155:Diphenhydramine; D008614:Meperidine; D008874:Midazolam; D005283:Fentanyl; D015742:Propofol